Safety Rates Drug Report: TYSABRI Multiple sclerosis relapse adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Drug: TYSABRI Injury: Multiple sclerosis relapse Quarter: 2016Q3

Total Records: 183 Number of Pages: 10

Event ID	DRUGNAME	PT	Drug Manufacturer	Patient Age	Sex	Weight	Date (YYYYMMDD)	Country
126001892	TYSABRI	Multiple sclerosis relapse	BIOGEN	54.61 YR	F	0	20160902	AU
126027621	TYSABRI	Multiple sclerosis relapse	BIOGEN	0.00	M	0	20160728	US
126049771	TYSABRI	Multiple sclerosis relapse	BIOGEN	0.00	F	0	20160728	US
126057562	TYSABRI	Multiple sclerosis relapse	BIOGEN	0.00	F	0	20160812	US
126101981	TYSABRI	Multiple sclerosis relapse	BIOGEN	0.00	F	0	20160801	US
126120201	TYSABRI	Multiple sclerosis relapse	BIOGEN	39.00 YR	F	67 KG	20160801	DE
126148331	TYSABRI	Multiple sclerosis relapse	BIOGEN	33.84 YR	F	0	20160802	US
126162152	TYSABRI	Multiple sclerosis relapse	BIOGEN	0.00	M	69 KG	20160809	CO
126179171	TYSABRI	Multiple sclerosis relapse	BIOGEN	0.00	M	0	20160803	US
126242521	TYSABRI	Multiple sclerosis relapse	BIOGEN	0.00	F	0	20160805	US
126269682	TYSABRI	Multiple sclerosis relapse	BIOGEN	53.93 YR	F	0	20160912	AU
126272931	TYSABRI	Multiple sclerosis relapse	BIOGEN	61.70 YR	F	0	20160805	US
126351521	TYSABRI	Multiple sclerosis relapse	BIOGEN	47.04 YR	M	0	20160808	DE
126367931	TYSABRI	Multiple sclerosis relapse	BIOGEN	0.00	F	0	20160809	US
126395251	TYSABRI	Multiple sclerosis relapse	BIOGEN	0.00	F	0	20160810	US
126426531	TYSABRI	Multiple sclerosis relapse	BIOGEN	0.00	F	0	20160810	US
126471581	TYSABRI	Multiple sclerosis relapse	BIOGEN	57.41 YR	M	0	20160812	US
126471651	TYSABRI	Multiple sclerosis relapse	BIOGEN	0.00	M	0	20160812	US
126475981	TYSABRI	Multiple sclerosis relapse	BIOGEN	47.65 YR	F	0	20160812	US
126482571	TYSABRI	Multiple sclerosis relapse	BIOGEN	0.00	F	63 KG	20160812	US

Total Records: 183 Number of Pages: 10